Ebola Vaccine Now Undergoing Trials In Canada January 15, 2015 By Caitlin Bradford Leave a Comment Ebola vaccination trials have begun in Canada. Officials have said that the vaccine will be tested with a small group of people to assess its safety, determine the appropriate dosage, and identify any possible side effects. According to a CBC news story, the trial is to take place in Halifax, Nova Scotia, where IWK Health Centre is looking for 40 people willing to volunteer for the study. The trial vaccine does not contain a live Ebola virus, and, according to the designers of the study, there is no risk that participants could contract the disease. While other trials will likely be conducted at later dates, the purpose of this specific study is to determine whether smaller doses of the vaccine could be as effective as a ‘normal’ dose. The specific vaccine, known as VSV-EBOV, is being tested in parts of the United States as well in hopes that an effective vaccine can reach the market in a shorter amount of time. Officials are hoping to have the results of the trial by early 2015. The Halifax study is just one of many Ebola vaccine studies currently being carried out across the globe in hopes of developing a vaccine before the West Africa outbreak spreads further. Although there have been no true Ebola outbreaks outside of Africa, such a possibility remains a global health concern. Ebola is primarily spread by direct contact with the bodily fluids of an infected person. It is not spread by air, water, or by food (generally), but the disease has a very high fatality rate. Disease symptoms include fever, severe headache, abdominal pain and unexplained hemorrhaging. Symptoms may appear anywhere from two to 21 days after exposure to Ebola. Recovery depends on good supportive clinical care and the health of the person’s immune system. According to the CDC, over 15,000 people have contracted Ebola world-wide, and just under 5,500 of those individuals have died from the virus in its latest outbreak. Would you be willing to participate in a minimal risk trial for an Ebola or other vaccine? Tell us below or on our Facebook page.